Walker Luke Nathaniel 4
4 · Context Therapeutics Inc. · Filed Sep 5, 2024
Insider Transaction Report
Form 4
Walker Luke Nathaniel
Director
Transactions
- Award
Stock Option (right to buy)
[F1]2024-09-04+19,315→ 19,315 totalExercise: $2.43Exp: 2034-09-03→ Common Stock (19,315 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable on the earlier of (i) June 13, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.
Signature
/s/ Alex Levit, Attorney-in-Fact|2024-09-05